SEI Investments
MLYS icon

SEI Investments’s Mineralys Therapeutics MLYS Stock Holding History

SEI Investments’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317K Buy
11,692
+2,912
+33% +$85.4K ﹤0.01% 2809
2025
Q4 		$319K Sell
8,780
-1,085
-11% -$43.5K ﹤0.01% 2707
2025
Q3 		$374K Buy
+9,865
New +$213K ﹤0.01% 2367

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

SEI Investments's MLYS Position: Q1 2026 in Review

SEI Investments increased its Mineralys Therapeutics (MLYS) stake by 33% in Q1 2026, buying an estimated $85.4K and bringing the position to 11,692 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

SEI Investments first reported a position in MLYS in Q3 2025 and has held it in 3 quarters since. The position peaked at $374K in Q3 2025. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • SEI Investments held 11,692 shares of Mineralys Therapeutics worth $317K as of Q1 2026.
  • SEI Investments bought 2,912 Mineralys Therapeutics shares in Q1 2026, an estimated $85.4K.
  • Mineralys Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2809 holding.
  • SEI Investments first reported a position in Mineralys Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • SEI Investments's Mineralys Therapeutics position peaked at $374K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.